# TMAO Supplementation to High-Carbohydrate Diet Reprogrammed Hepatic Metabolism and Intestinal Microbiota to Improve Liver Health and Disease Resistance of Micropterus salmoides

**Authors:** Weijun Tang, Yan Lei, Linyuan Jiang, Huijuan Ren, Shambel Boki, Xinyue Du, Kexin Xiong, Shihao Liu, Yaoqiang Yue, Qingchao Wang

PMC · DOI: 10.3390/microorganisms14020284 · Microorganisms · 2026-01-26

## TL;DR

Adding TMAO to a high-carb diet in largemouth bass improves liver health, metabolism, and disease resistance through changes in gut bacteria and liver function.

## Contribution

TMAO supplementation is shown to reprogram hepatic metabolism and enhance intestinal microbiota for improved fish health.

## Key findings

- TMAO reduced glycogen accumulation in the liver by altering gene expression related to glycogen metabolism.
- TMAO increased synthesis of long-chain fatty acids and amino acids while decreasing stress-related cortisol levels.
- TMAO enhanced disease resistance against Nocardia seriolae by boosting immune gene expression and reducing liver damage.

## Abstract

This study aimed to evaluate the effects of trimethylamine oxide (TMAO) supplementation (0.5% and 1%) to a high-carbohydrate diet on the growth performance, liver health, hepatic metabolome, intestinal microbiota and disease resistance of largemouth bass (Micropterus salmoides). After an eight-week feeding trial with three replicates, fish fed with TMAO-supplemented diets showed growth-promoting potential with increased difference with a prolonged rearing period. Importantly, TMAO supplementation significantly improved liver structure and function, with reduced intrahepatic glycogen accumulation due to reprogrammed glycogen metabolism, including down-regulated gys2 and ugp2b but up-regulated pygl expression levels. Targeted liver metabolomics analysis indicated the enhanced synthesis of long-chain fatty acid and amino acid in the 1% TMAO group, accompanied by decreased cortisol, indicating the attenuation of the stress response. Furthermore, TMAO supplementation changed the structure of the intestinal microbiota and particularly the intestinal content of Romboutsia, an important probiotic that can effectively utilize different kinds of dietary carbohydrate, showed an increasing trend with the increased TMAO supplementation levels. Finally, after sampling, all remaining fish were challenged with Nocardia seriolae. TMAO supplementation significantly enhanced the immune clearance function of largemouth bass against invading N. seriolae, with alleviated granulomatous nodules within liver but enhanced hepatic expression levels of nlrp3, caspase1, il-1β and il-18. These results collectively underscore the finding that TMAO may promote intestinal Romboutsia growth and reprogram hepatic metabolism to improve liver health, giving TMAO potential as a feed additive for growth and health promotion in largemouth bass.

## Linked entities

- **Genes:** GYS2 (glycogen synthase 2) [NCBI Gene 2998], ugp2b (UDP-glucose pyrophosphorylase 2b) [NCBI Gene 334420], PYGL (glycogen phosphorylase L) [NCBI Gene 5836], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], Caspase1 (caspase-1) [NCBI Gene 692604], IL1B (interleukin 1 beta) [NCBI Gene 3553], IL18 (interleukin 18) [NCBI Gene 3606]
- **Chemicals:** trimethylamine oxide (PubChem CID 1145), TMAO (PubChem CID 1145), cortisol (PubChem CID 5754)
- **Species:** Micropterus salmoides (taxon 27706), Romboutsia (taxon 1501226)

## Full-text entities

- **Diseases:** diabetes (MESH:D003920), Disease Resistance (MESH:D060467), acute pancreatitis (MESH:D010195), injury to (MESH:D014947), inflammation (MESH:D007249), impaired liver function (MESH:D008107), skin lesions (MESH:D012871), granulomatous (MESH:D013968), metabolic diseases (MESH:D008659), fatty liver disease (MESH:D005234), weight gain (MESH:D015430), glucogenic hepatopathy (MESH:D020754), N. seriolae infection (MESH:D007239), hepatic insulin resistance (MESH:D007333), viral diseases (MESH:D014777), nocardiosis (MESH:D009617), enteritis (MESH:D004751), bacterial infection (MESH:D001424), granuloma (MESH:D006099), Liver Health and (MESH:D017093)
- **Chemicals:** cortisol (MESH:D006854), nitrogen (MESH:D009584), xylene (MESH:D014992), pentose phosphate (MESH:D010428), acetonitrile (MESH:C032159), retinyl acetate (MESH:C009166), menadione sodium bisulphite (MESH:D024483), pyruvate (MESH:D019289), OCT (MESH:C051883), 4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid (MESH:C026219), paraffin (MESH:D010232), pyridoxine HCL (MESH:D011736), oxygen (MESH:D010100), sugar (MESH:D000073893), acid (MESH:D000143), TMAO (MESH:C005855), ascorbic acid (MESH:D001205), biotin (MESH:D001710), blood glucose (MESH:D001786), cholesterol (MESH:D002784), water (MESH:D014867), Glycogen (MESH:D006003), 2,6-diaminopimelic acid (MESH:D003960), NADPH (MESH:D009249), amino acid (MESH:D000596), cholecalciferol (MESH:D002762), Na2SeO3 (MESH:D018038), niacin (MESH:D009525), balsam (MESH:D001453), -Carbohydrate (MESH:D002241), fatty acid (MESH:D005227), riboflavin (MESH:D012256), serine (MESH:D012694), H&amp;E (MESH:D006371), dihydrogen citrate (-), glycerin (MESH:D005990), hematoxylin (MESH:D006416), linoleoyl ethanolamide (MESH:C109347), alcohol (MESH:D000438), eosin (MESH:D004801), PBS (MESH:D007854), SCFAs (MESH:D005232), MS-222 (MESH:C003636), CoCl2 (MESH:C018021), glucose (MESH:D005947), L-fucose (MESH:D005643), inositol (MESH:D007294), cyanocobalamin (MESH:D014805), tocopheryl acetate (MESH:D024502), agarose (MESH:D012685), sucrose (MESH:D013395), lipid (MESH:D008055), paraformaldehyde (MESH:C003043)
- **Species:** Ictalurus punctatus (channel catfish, species) [taxon 7998], Lactobacillus (genus) [taxon 1578], Acinetobacter (genus) [taxon 469], Cetobacterium (genus) [taxon 180162], Geomicrobium (genus) [taxon 767528], Romboutsia (genus) [taxon 1501226], Aeromonas (genus) [taxon 642], Cyanobacteriota (blue-green algae, phylum) [taxon 1117], Megalobrama amblycephala (blunt snout bream, species) [taxon 75352], Rattus norvegicus (brown rat, species) [taxon 10116], Nocardia seriolae (species) [taxon 37332], Staphylococcus (genus) [taxon 1279], Oncorhynchus mykiss (rainbow trout, species) [taxon 8022], Homo sapiens (human, species) [taxon 9606], Micropterus salmoides (largemouth bass, species) [taxon 27706], Fusobacteriota (phylum) [taxon 32066], Tilapia (genus) [taxon 8126], Mycoplasmatota (phylum) [taxon 544448], Bacillus (genus) [taxon 55087], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Weissella (genus) [taxon 46255], Portunus trituberculatus (Japanese blue crab, species) [taxon 210409], Penaeus vannamei (Pacific white shrimp, species) [taxon 6689]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942827/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942827/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942827/full.md

---
Source: https://tomesphere.com/paper/PMC12942827